PT  - JOURNAL ARTICLE
AU  - Marco Travaglio
AU  - Yizhou Yu
AU  - Rebeka Popovic
AU  - Nuno Santos Leal
AU  - Luis Miguel Martins
TI  - Links between air pollution and COVID-19 in England
AID  - 10.1101/2020.04.16.20067405
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.16.20067405
4099  - http://medrxiv.org/content/early/2020/04/28/2020.04.16.20067405.short
4100  - http://medrxiv.org/content/early/2020/04/28/2020.04.16.20067405.full
AB  - In December 2019, a novel disease, coronavirus disease 19 (COVID-19), emerged in Wuhan, People’s Republic of China. COVID-19 is caused by a novel coronavirus (SARS-CoV-2) thought to have jumped species from another mammal to humans. This virus has caused a rapidly spreading global pandemic. To date, thousands of cases of COVID-19 have been reported in England, and over 18,000 patients have died. While there has been progress in managing this disease, it is not clear which factors, in addition to age, affect the severity and mortality of COVID-19. A recent analysis of COVID-19 in Italy identified links between air pollution and death rates. Here, we explored potential links between three major air pollutants related to fossil fuels and SARS-CoV-2 mortality in England. We compared current, SARS-CoV-2 cases and deaths recorded in public databases to region-level air pollution data monitored at over 120 sites across England. We found that the levels of some markers of poor air quality, nitrogen oxides and ozone, were associated with COVID-19 mortality in different English regions, after adjusting for population density. We conclude that the levels of some air pollutants are linked to COVID-19 cases and morbidity. We consider that our study provides a useful framework to guide health policies in countries affected by this pandemic.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded by the UK Medical Research Council, intramural project MC_UU_00025/3 (RG94521).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData used for the statistical analyses will be available if requested https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases https://www.england.nhs.uk/statistics/statistical-work-areas/covid-19-daily-deaths/ SARSsevere acute respiratory syndrome